Announcements Trials
Browse Landscape

Phase

Phase 2 101Phase 1 42Phase 1/2 18Phase NA 10Phase 3 7Phase 2/3 4Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Recurrence 2Leukemia, Myeloid, Acute 2Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Lymphoid 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hematologic Neoplasms 1

Interventions

posaconazole 2fludarabine 2Cyclophosphamide 2Busulfan 2fludarabine phosphate 1eltrombopag 1Thiotepa 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Micafungin 1Idarubicin 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Decitabine 1Cytarabine 1Cholecalciferol 1Bone Marrow Transplantation 1Azacitidine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Myelodysplastic Syndromes × fludarabine phosphate × Clear all
NCT00361140 2017-03-03

Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)

H. Lee Moffitt Cancer Center and Research Institute

Phase 4 Completed
72 enrolled 10 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoid, Lymphoma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Hematologic Neoplasms, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡